🇺🇸 FDA
Patent

US 11285142

Compositions and methods for identifying and treating dystonia disorders

granted A61KA61K31/17A61K31/427

Quick answer

US patent 11285142 (Compositions and methods for identifying and treating dystonia disorders) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/17, A61K31/427, A61K31/47, A61K31/4706